Compare ASTE & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTE | BBNX |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2025 |
| Metric | ASTE | BBNX |
|---|---|---|
| Price | $45.16 | $29.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $41.00 | $28.09 |
| AVG Volume (30 Days) | 182.9K | ★ 618.5K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $1,368,800,000.00 | $88,570,000.00 |
| Revenue This Year | $8.19 | $52.13 |
| Revenue Next Year | $6.23 | $36.16 |
| P/E Ratio | $21.74 | ★ N/A |
| Revenue Growth | 6.66 | ★ 67.01 |
| 52 Week Low | $29.65 | $8.89 |
| 52 Week High | $50.83 | $32.71 |
| Indicator | ASTE | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 55.31 |
| Support Level | $43.29 | $27.87 |
| Resistance Level | $46.85 | $31.51 |
| Average True Range (ATR) | 1.47 | 2.09 |
| MACD | 0.48 | -0.22 |
| Stochastic Oscillator | 74.76 | 47.23 |
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.